financetom
Business
financetom
/
Business
/
Lineage Subsidiary Prices Senior Notes due 2031
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lineage Subsidiary Prices Senior Notes due 2031
Nov 19, 2025 2:19 PM

04:55 PM EST, 11/19/2025 (MT Newswires) -- Lineage (LINE) said Wednesday that its indirect subsidiary Lineage Europe Finco has priced an offering of 700 million euros ($807.6 million) of 4.125% senior notes due 2031 at 99.324% of the principal amount.

Net proceeds will be used to repay debt under a revolving credit facility and for general corporate and working capital purposes, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mosaic misses quarterly profit estimates
Mosaic misses quarterly profit estimates
Nov 12, 2024
Nov 12 (Reuters) - Fertilizer producer Mosaic missed Wall Street estimates for third-quarter profit on Tuesday, hurt by production snags due to operational issues. The Tampa, Florida-based company reported adjusted earnings of 34 cents per share for the quarter ended Sept. 30, compared with analysts' average estimate of 54 cents per share according to data compiled by LSEG. ...
AstraZeneca, Merck Trial of Koselugo Meets Primary Endpoint For Plexiform Neurofibromas
AstraZeneca, Merck Trial of Koselugo Meets Primary Endpoint For Plexiform Neurofibromas
Nov 12, 2024
07:19 AM EST, 11/12/2024 (MT Newswires) -- AstraZeneca ( AZN ) and Merck ( MRK ) said Tuesday their phase 3 study of Koselugo in adults with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas demonstrated a statistically significant and clinically meaningful objective response rate against placebo. Neurofibromatosis type 1 is a genetic condition in which about 30% to...
Avadel Pharmaceuticals' Q3 Loss Narrows, Revenue Rises
Avadel Pharmaceuticals' Q3 Loss Narrows, Revenue Rises
Nov 12, 2024
07:24 AM EST, 11/12/2024 (MT Newswires) -- Avadel Pharmaceuticals ( AVDL ) reported a Q3 loss Tuesday of $0.03 per diluted share, narrower than a loss of $0.41 a year earlier. Four analysts polled by Capital IQ expected a loss of $0.06. Revenue for the quarter ended Sept. 30 was $50 million compared with $7 million a year earlier. Analysts...
Bond hedge fund Arini up 23.4% betting against European satellites and autos, says letter
Bond hedge fund Arini up 23.4% betting against European satellites and autos, says letter
Nov 12, 2024
LONDON, Nov 12 (Reuters) - Former Credit Suisse bond trader Hamza Lemssouguer's main $3.7 billion fund at Arini jumped 23.4% through the end of October, benefiting from bets against European manufacturers facing U.S. and China headwinds, said a source and an investor letter. The year-to-date gains beat recent industry averages for hedge funds trading corporate debt, which have returned 9%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved